Coim PRSNT

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 30

“Patenting in Biotech & Pharma

Industry – An Industry Perspective”

Presentation by
Sandeep K. Rathod,
Head: Corporate & Formulations IP,
Matrix Laboratories Limited
[Subsidiary of Mylan Laboratories Inc.]

At:
NGM College, Pollachi, Coimbatore.
http://genericpharmaceuticals.blogspot.com 1
OBJECTIVES/
Contents for the day
1. Understand basic IPR concepts; and
their usage to our Industry.

2. Basics of a Patent and underlying concepts


within the Indian law;
and finally

3. Understand patenting in the Pharmaceutical and


Biotech arena, within the framework of Patents
Act, 1970 [India]

http://genericpharmaceuticals.blogspot.com 2
Intellectual Property:
An introduction
The property or product of one’s
mind or intellect.
Difference between intellectual property and
other forms of property:
Intellectual property is intangible i.e. it cannot
be defined or identified by physical parameters
but it needs to be expressed in some
discernible way to be protected

In business terms - proprietary knowledge

http://genericpharmaceuticals.blogspot.com 3
Intellectual Property
& it’s Types
IP can be traded/ protected/
enforced using legal means.
Types of Intellectual Property in
India:
 Trademarks [including geog.
indications]
 Patents
 Copyrights
 Designs
 Undisclosed Information

http://genericpharmaceuticals.blogspot.com 4
IPR Laws in India
 The Patents Act, 1970
[Act last amended in 2005]
 The Designs Act, 2000.
 The Copyright Act, 1957
 Trade & Merchandise Marks Act, 1999
 The Geographical Indications of Goods Act, 1999

http://genericpharmaceuticals.blogspot.com 5
Patent
A patent is:
 a grant of a limited time monopoly
 by the State to an inventor to stop others from
use, sell, distribute, license of his invention
 in return of it’s full disclosure which can be
used by the public after the expiry of its term.
A patent provides protection for the invention
to the owner of the patent for a limited period.
Duration: 20 years.

http://genericpharmaceuticals.blogspot.com 6
Copyright
The right of a person over an original work of art
is called as Copyright.
For e.g. Books/ Paintings etc.
Duration: Life of author + 60 years.

http://genericpharmaceuticals.blogspot.com 7
Design

Copyright in the external shape of an


object is protected by Design Rights.
The shape must be novel and possess
artistic merit.
Duration: 14 years

http://genericpharmaceuticals.blogspot.com 8
Undisclosed Information

Information that is kept and used as a


secret by a person and not open to
public is undisclosed information. Eg.
Coca-Cola Formula.
Duration: Till the information is kept a
secret.

http://genericpharmaceuticals.blogspot.com 9
Trademarks
The name by which an
entity sells a good or
delivers a service is
called “Trade-mark”.
Duration:
Continuous protection
till the proprietor uses
the same.

http://genericpharmaceuticals.blogspot.com 10
Geographical Indications
Simply put, a GI is similar to a trade mark.

Just like a TM indicates origin, a GI too assures a


buyer that the particular product has come from
a particular region [i.e. indicates origin].

But unlike a TM which is owned by one person/


company, a GI is usually owned by the Govt. or a
society/ group of producers.

http://genericpharmaceuticals.blogspot.com 11
Comprehensive Approach to the
Protection of Intellectual Property

Suppose you invent a pen, then the possibilities


are:
A Patent for any new technology underlying it,
Design for the appearance,
Trade Mark for its brand &
Copyright for the accompanying literature.

Now you will be in a position to


comprehensively cover your product by IP
rights.

http://genericpharmaceuticals.blogspot.com 12
Understanding Patent basics

CAPABLE OF
INVENTIVE STEP plus INDUSTRIAL EQUALS INVENTION
APPLICATION

GIVES

INVENTIONS NOT
PATENT GETS LESS NEW INVENTION
PATENTABLE

http://genericpharmaceuticals.blogspot.com 13
Patent Basics: Indian perspective [1]

“Inventive step”
means a feature that involves technical
advance [1] as compared to the existing
knowledge
or having economic significance [2]
or both
and that makes the invention not obvious [3]

to a person skilled in the art.

http://genericpharmaceuticals.blogspot.com 14
Obviousness – details [1]
 Based on sum total of knowledge
available on the relevant field

 Whether the "Invention" in question


will be obvious to a "Person Skilled in
the Art”

http://genericpharmaceuticals.blogspot.com 15
Obviousness – details [2]
 An invention will not be obvious:
Even if it does not solve a particular
problem
BUT
results in unexpected advantages.
 An invention will also not be obvious:
a) If there existed a long-felt problem
b) There was no known previous solution
c) Previous attempts to solve the
problem were unsuccessful

http://genericpharmaceuticals.blogspot.com 16
Patent Basics: Indian perspective [2]

“Capable of industrial application”


in relation to an invention means that the
invention is capable of being made or used in
an industry.

“Invention”
means a new product [1] or process [2]
involving an inventive step [3] and capable of
industrial application [4].

http://genericpharmaceuticals.blogspot.com 17
KINDS OF INVENTIONS

PROCESSES/
METHODS

ARTICLES
SUBSTANCES DEVICES

http://genericpharmaceuticals.blogspot.com 18
Patent Basics: Indian perspective [3]

“New Invention”
Means any invention or technology which
has not been anticipated by publication in
any document or used in the country or
elsewhere in the world before the date of
filing of patent application with complete
specification, i.e. the subject matter has not
fallen in public domain or that it does not
form part of the state of the art.

“Patent”
Means a patent for any invention granted
under the Patents Act.
http://genericpharmaceuticals.blogspot.com 19
Improvements: Invention?
Is an ‘Improvement’ an invention?
Inventiveness is a question of degree.
Simplest improvements may be inventive and
patentable.

Where the product is an improvement over a known


product.
E.g. An improved detergent and method for making
such an improved detergent having anti-static
properties

http://genericpharmaceuticals.blogspot.com 20
Inventions not patentable -1
The following are not inventions
within the meaning of the Patents Act:
(a) an invention which is frivolous or which claims anything obvious
contrary to well established natural laws;
(b) an invention the primary or intended use or commercial
exploitation of which would be contrary to public order or morality or
which causes serious prejudice to human, animal or plant life or
health or to the environment;
(e) a substance obtained by a mere admixture resulting only in the
aggregation of the properties of the components thereof or a process
for producing such substance;
(f) the mere arrangement or re-arrangement or duplication of known
devices each functioning independently of one another in a known
way;

http://genericpharmaceuticals.blogspot.com 21
Inventions not patentable - 2
The following are not inventions within the
meaning of the Patents Act:
(k) a mathematical method or a business method or a computer
program per se or algorithms
(l) a literary, dramatic, musical or artistic work or any other
aesthetic creation whatsoever including cinematographic works
and television productions;
(m) a mere scheme or rule or method of performing mental act or
method of playing game;
(n) a presentation of information;
(o) topography of integrated circuits;
(p) an invention which, in effect, is traditional knowledge or which is
an aggregation or duplication of known properties of traditionally
known component or components.

http://genericpharmaceuticals.blogspot.com 22
Inventions not patentable - 3
4. Inventions relating to atomic energy not
patentable
No patent shall be granted in respect of an invention
relating to atomic energy falling within sub-section (1) of
Section 20 of the Atomic Energy Act, 1962.

http://genericpharmaceuticals.blogspot.com 23
Inventions not patentable -4
The following are not inventions within the
meaning of the Patents Act:
(d) the mere discovery of a new form of a known
substance which does not result in the enhancement of
the known efficacy of that substance
or the mere discovery of any new property
or new use for a known substance
or of the mere use of a known process, machine or apparatus unless
such known process results in a new product or employs at least one
new reactant.
Explanation.—For the purposes of this clause, salts, esters,
ethers, polymorphs, metabolites, pure form, particle size,
isomers, mixtures of isomers, complexes, combinations and
other derivatives of known substance shall be considered to be
the same substance, unless they differ significantly in
http://genericpharmaceuticals.blogspot.com 24
properties with regard to efficacy;
Synergistic Compositions and S. 3d

admixtures of two or more components


combined in a predetermined proportion
 which do not chemically react with each
other, BUT
 physically interact
 to evince an improved or unexpected
property when put to use.

http://genericpharmaceuticals.blogspot.com 25
Inventions not patentable - 5
The following are not inventions within the
meaning of the Patents Act:
(c) the mere discovery of a scientific principle or the
formulation of an abstract theory or discovery of any
living thing or non-living substance occurring in nature;
(h) a method of agriculture or horticulture;
(i) any process for the medicinal, surgical, curative, prophylactic,
diagnostic, therapeutic or other treatment of human beings or any
process for a similar treatment of animals to render them free of
disease or to increase their economic value or that of their products.
(j) Plants and animals in whole or any part thereof other
than micro-organisms but including seeds, varieties and
species and essentially biological processes for
production or propagation of plants and animals;
http://genericpharmaceuticals.blogspot.com 26
Some ray of hope… YES
 A METHOD FOR PREPARING A DNA CONSTRUCT WITH
GLYPHOSATE TOLERANCE
Application: 477/MAS/2001, Patent: 194265,
Patentee: MONSANTO

 PROCESS FOR EXTRACTION OF SUPERIOR-QUALITY


PLASMID DNA
Application: 614/MAS/99, Patent: 193223,
Patentee: JAWAHARLAL NEHRU CENTRE FOR ADVANCED
SCIENTIFIC RESEARCH

 An in-vitro method for inserting a desired DNA


Application: 300/DEL/2002, Patent: 199927
Patentee: IDEC

http://genericpharmaceuticals.blogspot.com 27
Understanding Patent basics

CAPABLE OF
INVENTIVE STEP plus INDUSTRIAL EQUALS INVENTION
APPLICATION

GIVES

INVENTIONS NOT
PATENT GETS LESS NEW INVENTION
PATENTABLE

http://genericpharmaceuticals.blogspot.com 28
Biotech patent litigation in India
 INFECTIOUS BURSITIS VACCINE
 Application 136/CAL/98
 Invention is concerned with a vaccine which is capable
of protecting poultry against Infectious Bursitis Infections,
characterized in that it contains an Infectious Bursitis
virus which has the combined properties of upon
administration to a chicken causing a reduction in the
size of the bursal size, expressed as bursa/body weight
ratio, of less than 55% and the capability to protect
poultry having an ELISA antibody titer of at least about
500 and with viruses having the above characteristics.

http://genericpharmaceuticals.blogspot.com 29
Q&A
This completes my version of today’s talk.
I open the floor to Questions and Answers.

Site for Pharmaceutical news:


http://genericpharmaceuticals.blogspot.com

IP course for beginners [FREE]


http://academy.wipo.int [Check for DL 101]
Later on you could move to DL 204 [IP and biotech]

EMAIL ME AT <rathodsandeep@gmail.com>
THANK YOU.

http://genericpharmaceuticals.blogspot.com 30

You might also like